Compound K, a final intestinal metabolite of ginsenosides, enhances insulin secretion in MIN6 pancreatic β-cells by upregulation of GLUT2

Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets

Hisamitsu Ishihara, Tomoichiro Asano, Katsunori Tsukuda et al. · Diabetologia · 1993 · 453 citations · Full text

Molecular Physiology, Signal Transduction, Glucose Metabolism +10

DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATION

Mona Abdel‐Tawab, U. Bahr, Michael Karas et al. · Drug Metabolism and Disposition · 2003 · 433 citations

Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—The key step of inflammation

Eun‐Ha Joh, In‐Ah Lee, Il-Hoon Jung et al. · Biochemical Pharmacology · 2011 · 250 citations

Inflammation, Anti-inflammatory, Inflammatory Disease +10

Measurements of ATP in mammalian cells

Giovanni Manfredi · Methods · 2002 · 231 citations

Energy Metabolism, Biochemistry, Mitochondrial Function +8

GLUT2 in Pancreatic Islets: Crucial Target Molecule in Diabetes Induced With Multiple Low Doses of Streptozotocin in Mice

Zhiyong Wang, Helga Gleichmann · Diabetes · 1998 · 221 citations